With 18.52 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.84 million shares. The 52-week range on IBRX shows that it touched its highest point at $10.53 and its lowest point at $2.28 during that stretch. It currently has a 1-year price target of $12.19. Beta for the stock currently stands at 0.70.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IBRX was up-trending over the past week, with a rise of 23.03%, but this was up by 32.65% over a month. Three-month performance dropped to -19.92% while six-month performance fell -2.74%. The stock lost -18.41% in the past year, while it has gained 52.34% so far this year. A look at the trailing 12-month EPS for IBRX yields -0.89 with Next year EPS estimates of -0.67. For the next quarter, that number is -0.20. This implies an EPS growth rate of 30.43% for this year and 16.25% for next year. EPS is expected to grow by 32.58% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 1.17%.
Float and Shares Shorts:
At present, 696.83 million IBRX shares are outstanding with a float of 76.10 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for IBRX since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.5913 being high and -$1 being low. For IBRX, this leads to a yearly average estimate of -$0.8. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.